Benzinga··PrnewswireBrainStorm Appoints Former FDA Official as Board Bolsters ALS Trial Push
BrainStorm appoints former FDA Associate Commissioner Peter Pitts to board ahead of Phase 3b ALS trial launch with historic FDA Special Protocol Assessment.
BCLIstem cell therapyNurOwn